ClinicalTrials.Veeva

Menu

Intervention for Smoking Cessation in Pre-Surgical Patients.

V

Vall d'Hebron University Hospital (HUVH)

Status

Enrolling

Conditions

Surgical Procedure, Unspecified
Smoking
Smoking Cessation

Treatments

Behavioral: Intensive intervention for smoking cessation
Behavioral: Brief intervention for smoking cessation

Study type

Interventional

Funder types

Other

Identifiers

NCT05961813
PR-483/2021

Details and patient eligibility

About

The goal of this clinical trial is to assess efficacy of an intensive pre-surgical intervention to quit smoking in smoking patients who will be operated on implant orthopedic surgery or general and urological surgery. The main question[s] it aims to answer are:

  • Evaluate the efficacy of intensive pre surgical intervention to quit smoking compared to a brief intervention
  • Evaluate the implementation of this protocol.

Participants will be randomized to 2 intervention groups (patients programmed for protesic implant orthopedic surgery in the first group, and general and urological surgery) and 2 control groups (stratified in the same manner as the intervention groups), and will be monitored through telematic check ups via phone calls.

Full description

  1. Subject recruitment in pre surgical anesthesiology consults, data collection and randomization within 48 hours of said visit.
  2. Subjects in the intensive intervention group will be sent to a specialized Preventive Medicine consult for smoking cessation, completing 6 visits (2 before surgical intervention, 4 visits withint the following 12 months). Subjects in the control group will receive brief advice on quitting smoking through a phone call the the same day randomization is performed. Both groups will receive follow up calls at months 1, 3, 6, and 12, after surgical intervetion. All patients will have their smoking habits evaluated and the relevant data about the surgical intervention collected the day of the intervention.
  3. At month 7 adecuacy of the protocol will be evaluated to assess if any modifications are necessary.
  4. Data entry and quality control of the database will be performed periodically for the duration of the study.

Enrollment

232 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients must 18 years old or older, and be able to consent.
  • Surgery programmed for at least 4 weeks after inclusion in the study.
  • Smokers

Exclusion criteria

  • Pregnancy
  • Already under treatment for smoking cessation
  • Inability to consent due to cognitive impairment or language barrier.
  • Non-primary knee or hip replacement surgery
  • Participation in any study that forbids use of nicotine substitution therapy (dermal, oral)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

232 participants in 4 patient groups

Intervention group in protesic implant orthopedic surgery
Experimental group
Description:
58 patients programmed for knee or hip replacement surgeries, or spinal arthrodesis surgery who will be sent to a specialized preventive medicine consult to quit smoking.
Treatment:
Behavioral: Intensive intervention for smoking cessation
Intervention group in general and urological surgery
Experimental group
Description:
58 patients programmed for colorrectal surgery due to colorrectal cancer, cistectomy, radical prostatectomy and partial or total nefrectomy, who will be sent to a specialized preventive medicine consult to quit smoking.
Treatment:
Behavioral: Intensive intervention for smoking cessation
Control group in protesic implant orthopedic surgery
Active Comparator group
Description:
58 patients programmed for knee or hip replacement surgeries, or spinal arthrodesis surgery who will receive a brief intervention for smoking cessation.
Treatment:
Behavioral: Brief intervention for smoking cessation
Control group in general and urological surgery
Active Comparator group
Description:
58 programmed for colorrectal surgery due to colorrectal cancer, cistectomy, radical prostatectomy and partial or total nefrectomy, who will receive a brief intervention for smoking cessation.
Treatment:
Behavioral: Brief intervention for smoking cessation

Trial contacts and locations

1

Loading...

Central trial contact

Eva Gavilán Castillo, RN; MSN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems